‘We are more resilient and adaptable than we ever imagined’

The CSL and UQ COVID-19 vaccine candidate may have been abandoned, but this doesn’t detract from the biotech giant’s ‘Team Australia’ efforts.

CSL CEO Paul Perreault has been a critical leader in the country's response to COVID-19. Eamon Gallagher

Yolanda RedrupRich List editor

Dec 18, 2020 – 12.15am

Email LinkedIn Twitter Facebook

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

When the world went into lockdown in March, CSL chief executive Paul Perreault felt a strong personal and professional desire to assist. So the sting of the failure of the biotech giant and the University of Queensland to develop a home-grown COVID-19 vaccine is extra sharp.

But risk is the name of the game in biotech innovation and Perreault knew the odds when getting involved in the project.

Email LinkedIn Twitter Facebook

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

License article

Introducing your Newsfeed

Follow the topics, people and companies that matter to you.

Find out more

Yolanda RedrupRich List editorYolanda Redrup is the editor of the AFR Rich List. She previously reported on technology, healthcare and Street Talk.